Quality of Life in Patients With Inoperable Malignant Bowel Obstruction

NCT02365584 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

43

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated early due to insufficient recruitment.

Conditions

Intestinal Obstruction

Interventions

DRUG: lanreotide (Autogel formulation)

Sponsor

Ipsen